Modulation of Cognitive Flexibility by Tyrosine Depletion and Transcranial Direct Current Stimulation
NCT ID: NCT03462303
Last Updated: 2018-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2018-02-12
2018-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The next step involves finding a way of lowering dopamine concentrations while anodal (i.e. excitatory) stimulation of the dlPFC is applied and cognitive flexibility measured. One experimental approach to reduce global DA synthesis and transmission is through acute phenylalanine and tyrosine depletion (APTD). This dietary intervention involves the administration of an amino-acid mixture lacking in tyrosine and phenylalanine, which can be used to selectively lower DA synthesis in humans.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mod of Cognitive Flexibility by tDCS, Tyrosine Polymorphisms in the COMT Gene
NCT03845920
Cognitive Embodiment Activation by tDCS
NCT03094520
Effects of Transcranial Oscillatory Direct Current Stimulation on the Functions of Cerebral Cortex in Healthy Subjects
NCT06076044
Modulation and Assessment of Mental Flexibility in Dysexecutive Brain Patients
NCT04253522
Tactile Stimulation in Disorders of Consciousness (DoC)
NCT06922123
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
tDCS sham + balanced drink
Sham tDCS and balanced drink
Transcranial direct current stimulation (sham) of the dlPFC in combination with a drink containing both tyrosine and phenylalanine.
tDCS sham + tyrosine depleted drink
Sham tDCS and tyrosine depleted drink
Transcranial direct current stimulation (sham) of the dlPFC in combination with a tyrosine and phenylalanine free product.
tDCS anodal + balanced drink
Anodal tDCS and balanced drink
Transcranial direct current stimulation (anodal) of the dlPFC in combination with a drink containing both tyrosine and phenylalanine.
tDCS anodal +tyrosine depleted drink
Anodal tDCS and tyrosine depleted drink
Transcranial direct current stimulation (anodal) of the dlPFC in combination with a tyrosine and phenylalanine free product.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sham tDCS and tyrosine depleted drink
Transcranial direct current stimulation (sham) of the dlPFC in combination with a tyrosine and phenylalanine free product.
Anodal tDCS and tyrosine depleted drink
Transcranial direct current stimulation (anodal) of the dlPFC in combination with a tyrosine and phenylalanine free product.
Sham tDCS and balanced drink
Transcranial direct current stimulation (sham) of the dlPFC in combination with a drink containing both tyrosine and phenylalanine.
Anodal tDCS and balanced drink
Transcranial direct current stimulation (anodal) of the dlPFC in combination with a drink containing both tyrosine and phenylalanine.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* You are aged between 18 and 30 years
* You are in good health
* You agree to fast overnight prior to testing
Exclusion Criteria
* Damaged or diseased skin on your face and scalp, or a sensitive scalp
* A history of alcohol or drug addiction, or severe psychiatric illness
* Are in drug treatment which may lower seizure threshold (i.e. epilepsy)
* You are pregnant
* Slept less than 6 hours prior to coming to the lab
* Suffer from phenylketonuria
* A history of or current experience of migraine or headaches
* A history of or current use of antidepressants
* A history of or current use of tyrosine supplements
* Consume more than five beverages containing caffeine per day
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheffield Hallam University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Psychology labs
Sheffield, South Yorkshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SheffieldHallamAquili2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.